TRAVERE THERAPEUTICS, INC. (TVTX)

SEC filing

TRAVERE THERAPEUTICS, INC.

TVTX · CIK 1438533

4 · Sep 3, 2026 · CHIEF FINANCIAL OFFICER Cline Christopher R. sold 642 shares at $66.37/share ($42,610)

CHIEF FINANCIAL OFFICER Cline Christopher R. sold 642 shares at $66.37/share ($42,610)

xslF345X06/form4-09032026_040908.xml

xslF345X06/form4-09032026_040908.xmlSEC.gov

Graphics and non-inline formats (not embedded below).